Core Alternative Capital’s ResMed RMD Stock Holding History

Core Alternative Capital’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2	Closed	-$547	–	317
2025 Q3	$547	Hold	2	–	–	﹤0.01%	315
2025 Q2	$516	Hold	2	–	–	﹤0.01%	314
2025 Q1	$448	Hold	2	–	–	﹤0.01%	316
2024 Q4	$457	Hold	2	–	–	﹤0.01%	335
2024 Q3	$488	Hold	2	–	–	﹤0.01%	336
2024 Q2	$383	Hold	2	–	–	﹤0.01%	344
2024 Q1	$396	Sell	2 -40	-95%	-$7.33K	﹤0.01%	337
2023 Q4	$7.24K	Sell	42 -2	-5%	-$307	﹤0.01%	336
2023 Q3	$6.52K	Hold	44	–	–	﹤0.01%	360
2023 Q2	$9.63K	Buy	44 +4	+10%	+$892	﹤0.01%	319
2023 Q1	$8.77K	Buy	40 +2	+5%	+$434	﹤0.01%	330
2022 Q4	$7.92K	Hold	38	–	–	﹤0.01%	316
2022 Q3	$8K	Hold	38	–	–	﹤0.01%	318
2022 Q2	$8K	Buy	38 +12	+46%	+$2.56K	﹤0.01%	320
2022 Q1	$6K	Buy	26 +21	+420%	+$5.08K	﹤0.01%	337
2021 Q4	$1K	Buy	+5	New	+$1.3K	﹤0.01%	408

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Core Alternative Capital's RMD Position: Q4 2025 in Review

Core Alternative Capital sold out of ResMed (RMD) in Q4 2025, closing a stake of 2 shares — an estimated $547 sold.

Core Alternative Capital first reported a position in RMD in Q4 2021 and held it in 16 quarters. The position peaked at $9.63K in Q2 2023. 948 funds tracked by Wall St. Rank hold RMD as of Q4 2025.

Core Alternative Capital reported no remaining ResMed position as of Q4 2025 after selling out during the quarter.
Core Alternative Capital sold 2 ResMed shares in Q4 2025, an estimated $547.
Core Alternative Capital first reported a position in ResMed in Q4 2021 and held it in 16 quarters.
Core Alternative Capital's ResMed position peaked at $9.63K in Q2 2023.
948 funds tracked by Wall St. Rank held ResMed as of Q4 2025.

Based on Core Alternative Capital's 13F filing for Q4 2025, filed 2 Feb 2026.